The acquisition expands Aurora Cannabis's pharmaceutical footprint in the UK.
Aurora Cannabis has acquired two UK pharmaceutical companies for £2.1 million. The deal aims to strengthen the company’s presence in the UK healthcare market.
Further details about the acquired firms or the strategic rationale were not immediately available.
Priya covers listed equities and corporate earnings, reading quarterly results and guidance for what they signal about sector health and forward valuations.
More from Priya Anand →
